Stay informed with the latest updates for the inheritable blood disorders community. Industry BioMarin Receives Conditional Approval in Europe for Gene TherapyAug 25, 2022 Medical PPTA Posts Statement on Monkeypox and Plasma Protein TherapiesAug 22, 2022 Industry BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTHAug 4, 2022 Industry New Prophylaxis Approval for REBINYN®Aug 3, 2022 Industry Sanofi Provides Fitusiran Trial Updates at ISTHJul 25, 2022 Industry Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…Jul 22, 2022 Industry Sanofi and Sobi® Report Progress with BIVV001 at International Congress Jul 20, 2022 Medical New Genotyping Recommendations Issued by MASACJul 15, 2022 Medical National Hemophilia Foundation…Jul 8, 2022 Medical DESMOPRESSIN UPDATE: NOTICE TO PATIENTS – INCORRECT EXPIRATION DATE…Jun 28, 2022 Medical Novel Pilot Program to Focus on Genetic Diseases and Precision Medicine Jun 17, 2022 Industry Bayer Announces Discontinuation of Kogenate® FSJun 2, 2022 Industry FDA Grants Breakthrough Status to BIVV001 Jun 1, 2022 Industry FDA Accepts Priority Review BLA for Hemophilia B Gene TherapyMay 24, 2022 Medical Bone Health in VWD and Hemophilia Carriers the Focus of Retrospective…May 9, 2022 Pagination First page Previous page Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page